News from array biopharma inc

Jun 11, 2014, 14:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities 2014...

Jun 02, 2014, 13:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Two Array-Invented MEK Inhibitors Showcased At ASCO

Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and selumetinib, were showcased at the 50th annual meeting of the American...

May 28, 2014, 09:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec

 Array BioPharma (Nasdaq: ARRY) announced today a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of...

May 27, 2014, 17:30 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The Jefferies 2014 Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2014 Global...

May 19, 2014, 15:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Announces Key Additions To Scientific Leadership

Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small...

May 14, 2014, 08:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Announces Clinical Data Presentations At The 2014 ASCO Annual Meeting

Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and...

May 12, 2014, 12:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill...

Apr 29, 2014, 08:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2014

Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the third quarter of its fiscal year ending June 30, 2014. Revenue for the third...

Apr 28, 2014, 16:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Charles M. Baum, M.D., PH.D. Joins Array BioPharma Board Of Directors

Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization,...

Apr 23, 2014, 18:30 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014

 Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2014 and hold a conference call to...

Apr 23, 2014, 13:22 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Binimetinib Continues To Advance In Clinical Development

 Following the recent announcement by Novartis and GlaxoSmithKline that they have entered into a definitive agreement to exchange certain...

Mar 03, 2014, 08:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Provides Clinical Update On ARRY-502 For Asthma At Scientific Meeting

Array BioPharma Inc. (NASDAQ: ARRY) reported full results from a randomized Phase 2 trial of ARRY-502 in patients with mild to moderate Th2-Driven...

Feb 18, 2014, 12:45 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The RBC Capital Markets Global Healthcare And Cowen Annual Healthcare Conferences

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the RBC Capital Markets Global...

Feb 06, 2014, 16:30 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann...

Feb 04, 2014, 08:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2014

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter of its fiscal year ending June 30, 2014. Revenue for the...

Jan 29, 2014, 11:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2014 on February 4, 2014

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2014 and hold a conference call to discuss...

Jan 03, 2014, 13:30 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare...

Dec 09, 2013, 12:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting

 Earlier today, Array BioPharma Inc. (NASDAQ: ARRY) announced updated clinical safety and efficacy data on ARRY‑614 in patients with...

Dec 09, 2013, 08:30 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting

Array BioPharma Inc. (NASDAQ: ARRY) announced positive data for newly named filanesib (ARRY-520) as a single agent and in combination with...

Nov 21, 2013, 08:00 ET
Array BioPharma.  (PRNewsFoto/Array BioPharma Inc.)

Array BioPharma Announces Management Team Change

 Array BioPharma Inc. (NASDAQ: ARRY) announced today that Kevin Koch, Ph.D., President and Chief Scientific Officer, will be leaving Array to...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer